•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
DSC Joint Stock Company (DSC) increased its stake in Vietnam Dược liệu Joint Stock Company (HNX: DVM) to nearly 14%, buying additional shares in the trading session on April 15.
DSC purchased more than 2.8 million shares of DVM on April 15, increasing its ownership from 7.88% to 13.9%, equivalent to 6.54 million shares.
One day earlier, on April 14, DSC bought more than 1.8 million shares of DVM, moving from 4.05% (1.9 million shares) to 7.88% (3.7 million shares), which made DSC a major shareholder.
Based on the closing prices across the two sessions, DSC is estimated to have spent about VND 37 billion to raise its stake in DVM.
For 2025, DVM reported net revenue of VND 1,451 billion, down 8% year-on-year, mainly attributed to competitive pressures in the pharmaceutical industry and price bidding policies that affected selling prices.
Financial income fell 66% to VND 1.6 billion, while administrative expenses rose 47% to nearly VND 42 billion. As a result, net profit decreased 17% to nearly VND 40 billion.
Over the past two years, DVM’s share price on the Hanoi exchange has been volatile. After peaking above VND 10,000 per share in mid-2024, the stock entered a prolonged downtrend, briefly retreating to around VND 5,000 in early February 2026. Following a bottom formation, the shares rebounded, recently trading at around VND 8,500 per share with improved liquidity.
Separately, DVM said it will extend the timing of its 2026 annual general meeting of shareholders to before 30 June 2026, meaning this year’s business plans have not yet been announced.
Khang Di
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
